CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 17 enrolled
Drug / intervention
ArcticLine Cardiac Cryoablation Catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03604263
NCT03604263N/ACompleted
CompareCT.gov

ArcticLine Feasibility Study

Medtronic Cardiac Ablation Solutions·interventional·Posted Jul 27, 2018·Updated Feb 13, 2025

In Brief

A clinical study evaluating ArcticLine Cardiac Cryoablation Catheter for Atrial Fibrillation and Atrial Flutter. Completed, enrolled 17 participants across 4 sites in 2 countries.

Detailed Summary

The purpose of the ArcticLine Feasibility Study is to collect preliminary safety and effectiveness data on the ArcticLine Catheter.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtrial Fibrillation, Atrial Flutter
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 27, 2018
Enrollment StartOct 18, 2018
Primary CompletionNov 18, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 7.9 years ago

Interventions

ArcticLine Cardiac Cryoablation Catheterdevice

Cryoablation